Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Shree Ganesh Biotech (India) Ltd has submitted its Annual Secretarial Compliance Report (ASCR) for the financial year ended March 31, 2025 to BSE, Calcutta Stock Exchange, and Metropolitan Stock Exchange. The report was issued by Practicing Company Secretary Haresh Kapuriya of KH & Associates, Vadodara, as required under SEBI's Listing Regulations. It covers compliance with key SEBI regulations including the Listing Obligations & Disclosure Requirements (LODR) Regulations 2015, Prohibition of Insider Trading Regulations 2015, and Depositories Act provisions. The auditor confirmed the company complied with all applicable regulations, with no deviations, no prior non-compliance observations to rectify, and no penalties or actions taken by SEBI or stock exchanges against the company, its promoters, directors, or subsidiaries during the year.
This is a routine annual compliance filing with a clean report — no adverse findings, no fines, and no regulatory actions. Neutral to marginally positive for shareholders as it confirms the company met its SEBI regulatory obligations for FY25 without any flags.